Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
7.29
+0.06 (0.83%)
At close: Feb 27, 2026, 4:00 PM EST
7.28
-0.01 (-0.14%)
After-hours: Feb 27, 2026, 7:14 PM EST
Organon & Co. Employees
Organon & Co. had 10,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
10,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$621,600
Profits / Employee
$18,700
Market Cap
1.90B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 10,000 | 0 | - |
| Dec 31, 2023 | 10,000 | 0 | - |
| Dec 31, 2022 | 10,000 | 700 | 7.53% |
| Dec 31, 2021 | 9,300 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pfizer | 75,000 |
| Sanofi | 74,846 |
| GSK plc | 68,629 |
| Bristol-Myers Squibb Company | 32,500 |
| Grifols | 23,737 |
| Biogen | 7,500 |
| Amarin Corporation | 275 |
| Scilex Holding Company | 30 |
OGN News
- 22 hours ago - New Analysis of Organon's VTAMA® (tapinarof) cream, 1%, Phase 3 Data Showed Early and Consistent Improvement in Patient-Reported Sleep Subdomains in Pediatric Patients Down to 2 Years of Age with Atopic Dermatitis - Business Wire
- 4 days ago - Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals' Hormone-Free Intrauterine Device - Business Wire
- 6 days ago - Organon: Revenue Decline, Margin Pressure, And Strategic Uncertainty - Seeking Alpha
- 15 days ago - Organon Q4 Earnings Review: Poor Results Trigger Predictable Sell-Off - Seeking Alpha
- 15 days ago - Organon & Co. (OGN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025 - Business Wire
- 4 weeks ago - Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026 - Business Wire
- 4 weeks ago - Organon Completes Divestiture of JADA® System to Laborie - Business Wire